Background: Significant enhancement of sub-barrier fusion cross sections owing to neutron rearrangement with positive Q values were found for many combinations of colliding nuclei. However, several experimental results on fusion reactions were reported recently in which such enhancement has not been observed in spite of a possibility for neutron rearrangement with positive Q values. Purpose: We aim to clarify much better the mechanism of neutron rearrangement in sub-barrier fusion reactions to find the other requirements (beside positive Q values) which favor (or prevent) sub-barrier fusion enhancement. Methods: A channel coupling approach along with the semiclassical model for neutron transfer has been used for analysis of available experimental data on sub-barrier fusion of heavy ions. Results: The role and interplay of different factors determining the enhancement of sub-barrier fusion (such as Q values for neutron rearrangement, properties of collective excitations, and neutron binding energies) have been studied and clarified. Conclusions: (1) Only 1n and 2n transfers with positive Q values have a noticeable impact on sub-barrier fusion. A positive Q value for neutron rearrangement is a necessary but not sufficient requirement for additional sub-barrier fusion enhancement to take place. (2) The "rigidity" of colliding nuclei with respect to collective excitations is important for sub-barrier fusion enhancement due to neutron rearrangement with positive Q values to be clearly visible. (3) The neutron binding energy of the "donor" nucleus has a strong impact only in the case of fusion of light weakly bound nuclei.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.